Physician

Davendra P. Ramkumar, M.D.

According to 2025 Medicare claims, Davendra Ramkumar, M.D. (NPI: 1063420370) practices gastroenterology in the Champaign-Urbana, IL market, with the plurality of this provider's patient population coming from Champaign, IL. This provider's primary affiliated billing organization is CHRISTIE CLINIC, PLLC (NPI: 1871523829; TIN: 370802668) and primary practice location at 61822-3741. Ramkumar is affiliated with the Stratum Med ACO (ACO ID: A4527) and SBL accountable care organization (ACO ID: A5147), participating under the MSSP model.

Ramkumar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 443 traditional Medicare patients, billed 4,653 HCPCS/CPT codes, and received $148,452 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,635 prescription claims across 296 beneficiaries totaling $1,228,114 in drug costs, led by Linzess (Linaclotide). 2021 DME data shows 42 claims. Open Payments data shows 108 records totaling $2,550. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	444	1,612	$119,182
2016	548	1,625	$126,057
2017	525	1,511	$106,329
2018	465	1,675	$113,706
2019	430	1,647	$105,259
2020	317	1,629	$90,937
2021	402	2,014	$112,846
2022	452	6,982	$158,793
2023	460	6,561	$179,998
2024	443	4,653	$148,452

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	192	1,353	$1,314,281
2016	199	1,298	$1,125,424
2017	195	1,059	$882,642
2018	199	1,168	$437,156
2019	227	1,336	$717,762
2020	235	1,351	$1,233,717
2021	223	1,422	$1,078,696
2022	288	1,488	$1,200,571
2023	294	1,535	$1,425,421
2024	296	1,635	$1,228,114

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	69	$44,160
2021	N/R	42	$7,386
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	110	110	$179
45380	Biopsy of large bowel using a flexible endoscope	63	63	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	116	155	$85
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	136	209	$11
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito	209	214	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Linzess	Linaclotide	148	5,640	$99,881
Creon	Lipase/Protease/Amylase	42	1,679	$94,898
Mesalamine	Mesalamine	79	4,794	$37,228
Motegrity	Prucalopride Succinate	27	1,440	$25,524
Alosetron Hcl	Alosetron Hcl	30	900	$18,008

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	106	$1,759	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$791	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Davendra P. Ramkumar, M.D.?

Tedicare shows public-source Medicare data for Davendra P. Ramkumar, M.D. (NPI 1063420370), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Davendra P. Ramkumar, M.D. have ACO affiliation data?

Davendra P. Ramkumar, M.D. is shown with ACO affiliation data for Stratum Med ACO (MSSP, ACO ID A4527) and SBL accountable care organization (MSSP, ACO ID A5147).

What billing organization is linked to Davendra P. Ramkumar, M.D.?

Davendra P. Ramkumar, M.D. is linked to CHRISTIE CLINIC, PLLC (billing NPI 1871523829) in the available physician profile data.

Does Davendra P. Ramkumar, M.D. have Open Payments data?

Davendra P. Ramkumar, M.D. has 108 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.